| Dr Scott Wambolt, DO | |
|
5955 Zeamer Ave, Jber, AK 99506-3702 | |
| (774) 249-9643 | |
| Not Available |
| Full Name | Dr Scott Wambolt |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 7 Years |
| Location | 5955 Zeamer Ave, Jber, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427582881 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Matsu Emergency Medicine Physicians Corp | 1557251022 | 15 |
News Archive
A comprehensive review of all phase III clinical trials supported by one Federal agency finds that, estimated conservatively, the economic benefit in the United States from just eight of these trials exceeded $15 billion over the course of 10 years. The study also found that new discoveries from the trials were responsible for an estimated additional 470,000 healthy years of life. The clinical trials were sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).
Obsessive-compulsive disorder (OCD) is a mental health condition wherein people are caught in a cycle of obsessions. The rubber hand illusion therapy, whereby fake rubber hands are contaminated with feces, maybe the key in helping people overcome their fears of touching contaminated surfaces, a new study suggests.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.
› Verified 9 days ago
| Entity Name | Matsu Emergency Medicine Physicians Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073548129 PECOS PAC ID: 1557251022 Enrollment ID: O20040318000130 |
News Archive
A comprehensive review of all phase III clinical trials supported by one Federal agency finds that, estimated conservatively, the economic benefit in the United States from just eight of these trials exceeded $15 billion over the course of 10 years. The study also found that new discoveries from the trials were responsible for an estimated additional 470,000 healthy years of life. The clinical trials were sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).
Obsessive-compulsive disorder (OCD) is a mental health condition wherein people are caught in a cycle of obsessions. The rubber hand illusion therapy, whereby fake rubber hands are contaminated with feces, maybe the key in helping people overcome their fears of touching contaminated surfaces, a new study suggests.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Wambolt, DO 5955 Zeamer Ave, Elmendorf Afb, AK 99506-3702 Ph: () - | Dr Scott Wambolt, DO 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (774) 249-9643 |
News Archive
A comprehensive review of all phase III clinical trials supported by one Federal agency finds that, estimated conservatively, the economic benefit in the United States from just eight of these trials exceeded $15 billion over the course of 10 years. The study also found that new discoveries from the trials were responsible for an estimated additional 470,000 healthy years of life. The clinical trials were sponsored by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).
Obsessive-compulsive disorder (OCD) is a mental health condition wherein people are caught in a cycle of obsessions. The rubber hand illusion therapy, whereby fake rubber hands are contaminated with feces, maybe the key in helping people overcome their fears of touching contaminated surfaces, a new study suggests.
Al Jazeera examines how Iraq's public health system has been affected by the war and the challenges doctors in the country currently face. Iraq had 34,000 registered physicians before the U.S.-led invasion in 2003, and it is estimated that 20,000 of them have left the country, according to the Brookings Institution.
Sigma-AldrichCorporation, a leading Life Science and Technology company, announced today it signed an exclusive global distribution agreement with Roche. The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.
Exelixis, Inc. today reported preliminary data from a cohort of heavily pretreated patients with metastatic refractory renal cell carcinoma (RCC) participating in an ongoing phase 1b trial of cabozantinib.
› Verified 9 days ago
Dr. Joshua Ballard Pead, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 673d Mdg, 5955 Zeamer Avenue, Jber, AK 99506 Phone: 907-580-5556 | |
Taylor James Travers, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5556 | |
Dr. Mark Edward Shepherd Jr., M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, 673d Mdg, Jber, AK 99506 Phone: 907-580-5556 | |
Eli Lessard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5556 | |
Dr. Erin Mai, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, 673d Medical Group; Dept Of Emergency Medicine, Jber, AK 99506 Phone: 907-580-6280 | |
Nicholas C Papacostas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5556 Fax: 907-580-5556 | |
Mrs. Daniela Faith Feldhausen, EMPA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5556 |